BASEL, Switzerland,
Aug. 31, 2017 /PRNewswire/ -- Myovant
Sciences (NYSE: MYOV), a leading clinical-stage
biopharmaceutical company focused on women's health and endocrine
diseases, today announced that Lynn
Seely, M.D., President and Chief Executive Officer, will
present at Baird's 2017 Global Healthcare Conference in
New York City on September 7th at 12:15 p.m. Eastern Time.
The presentation and fireside chat will be webcast live and may
be accessed via the Events page under the Investors and Media
section of Myovant's website at myovant.com. Please connect to the
company's website at least 15 minutes prior to the presentation to
ensure adequate time for any software download that may be required
to listen to the webcast. A replay will also be available at the
same location for 30 days following the conference.
About Myovant Sciences
Myovant Sciences is a
clinical-stage biopharmaceutical company focused on developing and
commercializing innovative therapies for women's health and
endocrine diseases. Myovant's lead product candidate is relugolix,
an oral, once-daily, small molecule that acts as a GnRH receptor
antagonist. Myovant has initiated three clinical programs for
relugolix consisting of five international Phase 3 clinical trials,
two in women with heavy menstrual bleeding associated with uterine
fibroids, two in women with endometriosis-associated pain, and one
in men with advanced prostate cancer. Myovant is simultaneously
developing MVT- 602, a kisspeptin agonist, for the treatment of
female infertility as part of assisted reproduction. Over time, the
company intends to expand its development pipeline to include other
potential treatments for women's health and endocrine diseases. For
more information, please visit the company's website at
myovant.com.
Investor Contact:
Frank
Karbe
Chief Financial Officer
Myovant Sciences, Inc.
investors@myovant.com
Media Contact:
Julie
Normart
Pure Communications
jnormart@purecommunications.com
415.946.1087
View original content with
multimedia:http://www.prnewswire.com/news-releases/myovant-sciences-announces-upcoming-presentation-at-bairds-2017-global-healthcare-conference-300512089.html
SOURCE Myovant Sciences, Ltd.